Dr. Mathew is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Rose St, Cc401b
Lexington, KY 40536Phone+1 859-323-8043Fax+1 859-257-7715
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2012 - 2015
University of Kerala Medical CollegeClass of 2006
Certifications & Licensure
KY State Medical License 2015 - 2025
PA State Medical License 2012 - 2016
Publications & Presentations
PubMed
- A comparative study of cancer drug approvals in india and high-income countries.Arya Mariam Roy, Rachel Jones, Aju Mathew
Journal of Cancer Policy. 2022-09-01 - 4 citationsClinical Benefit of Comprehensive Genomic Profiling for Advanced Cancers in India.Aju Mathew, Serena Joseph, Jeffrey Boby, Steve Benny, Janeesh Veedu
JCO Global Oncology. 2022-03-01 - 2 citationsAccess to and affordability of cancer medicines: time to focus on the last mile.Bhawna Sirohi, Aju Mathew
The Lancet. Oncology. 2021-09-15
Journal Articles
- Combined Blockade of Activating ERBB2 Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast CancerAju Mathew, MD, Clinical Cancer Research
Press Mentions
Placebo, Palliative or Prescribed?February 18th, 2023- 30% of New Drugs Approved in India May Be Ineffective: StudyJuly 30th, 2022
- Study Bares Cancer’s Financial BurdenDecember 2nd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
